100% de satisfacción garantizada Inmediatamente disponible después del pago Tanto en línea como en PDF No estas atado a nada 4.2 TrustPilot
logo-home
Resumen

Summary Alzheimer's and dementia from clinical perspective

Puntuación
-
Vendido
-
Páginas
13
Subido en
24-11-2025
Escrito en
2025/2026

This is a summary of the lecture given by Prof. Dr. Engelborghs in the course Translational Neuroscience. The summary is based on the given slides and my own notes.

Institución
Grado











Ups! No podemos cargar tu documento ahora. Inténtalo de nuevo o contacta con soporte.

Escuela, estudio y materia

Institución
Estudio
Grado

Información del documento

Subido en
24 de noviembre de 2025
Número de páginas
13
Escrito en
2025/2026
Tipo
Resumen

Temas

Vista previa del contenido

Alzheimer’s and dementia from clinical
perspective (Prof. Dr. Engelborghs)
1. Epidemiology
 AD is an incurable disease but treatable
 Since 2023: dementia = 1st cause of death in Belgium
 develops dementia
 As age is main risk factor and given ageing population, number of people
with dementia is expected to have doubled in 2070
 Dementia = umbrella term
o Symptoms
 Memory loss
 Change of personality
 Less aware of danger/lack of insight
 Special impairment/lack of orientation in space and time
o It doesn’t say anything about the cause of the disease
o People with dementia have symptoms in 3 pilars
 Cognitive symptoms
 Change of personality and behavior
 Functional deficits: activities of daily living that can be very
basics are know very difficult
o Which disease causes dementia
 Most common cause is AD: 60-75%
 Vascular dementia: 20-30%
 Dementia with Lewy bodies: 10-25%
 Frontotemporal lobar degeneration (FTLD): 10-15%  really
causes memory loss
 The way that dementia represents is depended on the disease


2. Alzheimer’s disease (AD): the amyloid cascade
hypothesis
 Not everyone with AD has dementia  can’t diagnose dementia in the
stage of mild cognitive impairment


2.1. Amyloid cascade hypothesis
 (1) First thing that happens in the brain is the formation of amyloid
plaques
o Amyloid is being formed based on the precursor protein  formation
of amyloid of 42 amino acids  insoluble  clitting together in the
brain and forming plaques
o This is the first thing that happens in the brain for AD
 (2) Second thing that happens
o Protein tau: basis of cytoskelet of neurons
o This protein gets phosphorylated leading to the effect that tau
protein loses its functions  aggregates  form deposits within the
neurons
 Deposits are neurofibrillary tangles

1

,  (3) Neurons start degenerating  connect to each other
o Create brain network
 (4) Number of synaps per neuron are decreasing  brain network is
defected
 (5) Loss of neurons themselves
o Brain shrinks
o Coronal section on the level of the temporal lobe
 Hippocampus is important to transfer new information to your
permanent memory
 Atrophy is maximal in hippocampus
 Recent memory problems are the most common results from
this
 If you’re able to wash these plaques away you can ‘cure’ AD

1 2
3




4
5




2.2. Sequence of spread of neurofibrillary tangles
 Inner part of the right hemisphere
 Red color shows you the spread of the neurofibrillary tangles
o The darker the denser the neurofibrillary tangles
 Huge damage in the brain but not the whole brain is affected
o Some parts are more affected than other
o Darker spots  so the disease started there
o Selectively defects brain region
 Early dementia stage and damage is huge  started very early
 Mild cognitive impairment
 People that have memory problems but no other symptoms  don’t have
dementia because they don’t have symptoms in the other pilars
 First symptoms of AD are seen here
 10-20 years before the first symptoms




2

,3

, 2.3. The Alzheimer continuum
 Shows that you spend the majority of the disease in the preclinical stage
o Building the pathology without showing symptoms
 Mild cognitive impairment (MCI) is the first stage where you see symptoms
 Only people with MCI and mild dementia can be treated




3. Diagnosing Alzheimer’s disease
3.1. (Biomarker) changes throughout the AD continuum
 How do we diagnose AD?  biomarkers of the disease are used
 Colored curves are different markers they used in clinical practice
 Move from normal to abnormal throughout the different stages of the
disease
o Preclinical
o MCI
o Dementia




 Brown curve: activities of daily living (ADL)
o MCI have no functional deficits
 Purple is neuropsychological examination
o Psychologist trained to diagnose deficits
o Testing different cognitive function through standardized cognitive
tests
 Use battery of test to cover all cognitive domains
 Someone of the age of 70 with this educational level should
score this
 Score lower = deficits for this
 Cognitive functions are normal for age and … = no problem



4
$6.62
Accede al documento completo:

100% de satisfacción garantizada
Inmediatamente disponible después del pago
Tanto en línea como en PDF
No estas atado a nada

Conoce al vendedor
Seller avatar
WillemsenAmber
4.0
(1)

Documento también disponible en un lote

Conoce al vendedor

Seller avatar
WillemsenAmber Universiteit Antwerpen
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
10
Miembro desde
1 año
Número de seguidores
0
Documentos
45
Última venta
1 semana hace

4.0

1 reseñas

5
0
4
1
3
0
2
0
1
0

Recientemente visto por ti

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes